Ketamine is not inherently dangerous at medical doses, but it can cause serious harm depending on how it’s used, how often, and in what setting. The drug has a wide margin of safety in clinical environments. The FDA’s own prescribing information notes that even accidental overdoses up to ten times the normal amount have been followed by prolonged but complete recovery. That said, chronic recreational use carries real risks to the brain, bladder, and cardiovascular system that supervised medical use largely avoids.
How Ketamine Affects the Brain
Ketamine works by blocking a specific receptor involved in how brain cells communicate. When those receptors are blocked, something counterintuitive happens: certain inhibitory neurons get shut down, which causes a surge of activity in other parts of the brain. This cascade of excitation and inhibition creates unusual patterns of brain waves, particularly in the prefrontal cortex. At low doses, this produces feelings of dissociation, pain relief, and sedation. At high doses, it causes unconsciousness.
That same mechanism is also what makes ketamine useful for depression. The burst of neural activity it triggers appears to kick off a chain reaction of changes in brain connections, which is why some people with treatment-resistant depression feel relief within hours rather than the weeks that traditional antidepressants require.
Short-Term Side Effects
Even in controlled medical settings, ketamine reliably produces several short-term effects. Blood pressure typically rises, peaking about 40 minutes into an infusion with an average increase of roughly 16 points systolic and 11 points diastolic. In one study of 84 patients receiving ketamine infusions, 20 to 30 percent experienced blood pressure exceeding 180/100 or a heart rate above 110 beats per minute, and some required medication to bring it back down.
Dissociation is the other signature effect. You may feel detached from your body, experience distorted perception, or feel as though your surroundings aren’t real. Nausea, dizziness, and sedation are common. In a medical setting, these effects are monitored and typically resolve within a couple of hours. The FDA-approved nasal spray version of ketamine (esketamine, sold as Spravato) carries a boxed warning for sedation, dissociation, respiratory depression, and the potential for abuse.
What Chronic Use Does to the Bladder
The bladder is one of the organs most vulnerable to repeated ketamine exposure, and this risk is almost entirely tied to heavy, long-term recreational use. Frequent users develop a condition sometimes called ketamine-induced cystitis, which involves painful and urgent urination, blood in the urine, waking up multiple times a night to urinate, and a bladder that progressively shrinks in capacity. In severe cases, the bladder lining ulcerates and becomes inflamed.
The damage can extend beyond the bladder itself. Heavy users sometimes develop a condition where urine backs up toward the kidneys, leading to kidney function impairment. The exact mechanism isn’t fully understood, though researchers have identified disruptions in the signaling pathways that control bladder muscle contractions. These symptoms can improve if use stops early enough, but advanced cases sometimes require surgical intervention.
What Chronic Use Does to the Brain
A neuroimaging study comparing 41 people with ketamine dependence to 44 healthy volunteers found measurable damage to the brain’s white matter, the tissue that connects different brain regions and allows them to communicate efficiently. The damage was concentrated in the frontal lobes on both sides and in the left side of the brain near the junction of the temporal and parietal lobes.
Critically, the damage was dose-dependent. The more ketamine someone had consumed over their lifetime (measured in total grams), the worse the white matter deterioration in the frontal regions. The frontal lobes govern decision-making, impulse control, and working memory, which helps explain the cognitive difficulties that chronic users often report: trouble concentrating, memory lapses, and difficulty planning ahead.
Medical Use vs. Recreational Use
The gap between supervised ketamine therapy and recreational use is enormous, and most of the serious harms described above cluster on the recreational side. A clinical dose for a procedure typically falls in the range of 3 to 5 milligrams per kilogram of body weight. For depression treatment, doses are much lower (subanesthetic), and the FDA-approved nasal spray uses either 56 or 84 milligrams per session. During an induction phase for treatment-resistant depression, sessions happen twice a week for four weeks, then taper to once weekly or every two weeks.
In a clinic, you’re monitored with pulse oximetry, vital signs checks, and sedation scoring from the moment the drug is administered until its effects wear off. A provider trained in advanced cardiac life support is required to be on-site. The infusion runs through a dedicated line with a controlled pump. This level of oversight catches cardiovascular spikes early and prevents the kind of repeated, uncontrolled exposure that leads to bladder and brain damage.
Recreational users, by contrast, often use ketamine far more frequently (sometimes daily), at unpredictable doses, with no monitoring. That pattern of heavy, repeated exposure over months or years is what drives the chronic harms to the bladder and white matter.
Contamination Risks With Street Ketamine
If you’re using ketamine outside a medical setting, the drug itself isn’t the only danger. The DEA’s 2025 National Drug Threat Assessment describes a landscape where drug mixtures have become “the new normal rather than the exception.” Cartels now produce blends marketed under names like “tusi” that combine ketamine with cocaine, methamphetamine, or fentanyl. These mixtures are impossible to identify without laboratory analysis.
Fentanyl contamination is widespread across the illicit drug supply. In 2024, more than one in four cocaine samples submitted to forensic labs contained fentanyl. Ketamine appears both as a standalone product that may be adulterated and as an ingredient mixed into other drugs. A dose of fentanyl measured in micrograms can be lethal, so even trace contamination in a batch of ketamine introduces a risk of fatal overdose that has nothing to do with ketamine’s own pharmacology.
Addiction Potential
Ketamine is a Schedule III controlled substance, meaning it has recognized medical value but also a real potential for dependence. The FDA’s boxed warning on esketamine explicitly flags abuse and misuse as concerns. Tolerance builds with repeated use, meaning people need progressively larger amounts to achieve the same effect. This escalating pattern is what pushes recreational users into the high-dose, high-frequency territory where bladder and brain damage become likely.
Psychological dependence is more common than physical withdrawal symptoms, though heavy users who stop abruptly can experience cravings, anxiety, and sleep disturbances. The dissociative “escape” ketamine provides is part of what makes it habit-forming for some people, particularly those already dealing with depression, trauma, or chronic pain.
Who Faces the Greatest Risk
People with existing cardiovascular conditions face elevated risk even from supervised ketamine use, since blood pressure and heart rate increases are essentially guaranteed. Anyone with a history of substance use disorder needs careful consideration before starting ketamine therapy, given its abuse potential. Bladder damage disproportionately affects young, heavy recreational users, sometimes appearing in people in their twenties who have been using frequently for just one to two years.
For someone receiving ketamine in a clinical setting at approved doses and frequencies, the risk profile is manageable and well-characterized. For someone using street ketamine regularly, the risks compound: unpredictable doses, possible fentanyl contamination, cumulative organ damage, and a path toward dependence that makes stopping harder over time.